Crédit Industriel et Commercial’s Boston Scientific BSX Stock Holding History

Crédit Industriel et Commercial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,900	Closed	-$1.75M	–	364
2025 Q3	$1.75M	Hold	17,900	–	–	0.15%	147
2025 Q2	$1.92M	Buy	+17,900	New	+$1.81M	0.16%	145

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Crédit Industriel et Commercial's BSX Position: Q4 2025 in Review

Crédit Industriel et Commercial sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 12,829 shares — an estimated $1.25M sold.

Crédit Industriel et Commercial first reported a position in BSX in Q2 2025 and held it in 2 quarters. The position peaked at $1.25M in Q3 2025. 1,785 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Crédit Industriel et Commercial reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 12,829 Boston Scientific shares in Q4 2025, an estimated $1.25M.
Crédit Industriel et Commercial first reported a position in Boston Scientific in Q2 2025 and held it in 2 quarters.
Crédit Industriel et Commercial's Boston Scientific position peaked at $1.25M in Q3 2025.
1,785 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q4 2025, filed 3 Feb 2026.